Medicine for treating tinea pedis
A drug and technology for tinea pedis, applied in the field of biomedicine, can solve problems such as difficulty in completing a prescribed course of treatment, stubborn tinea pedis infection, and poor compliance.
Inactive Publication Date: 2016-03-16
史克勇
View PDF2 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Tinea pedis infection is usually stubborn, easy to repeat, long course of medication, cumbersome application, resulting in poor compliance, it is difficult to complete the prescribed course of treatment, and the recurrence rate remains high
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0007] Embodiment 1. The present invention is made up of the raw material of following mass ratio: 40 parts of big maple fruit, 10 parts of Sophora flavescens, 20 parts of Cortex Phellodendri, 30 parts of Fructus Cnidii, 10 parts of rhubarb.
Embodiment 2
[0008] Embodiment 2. The present invention is made up of the raw material of following mass ratio: 20 parts of Dafengzi, 30 parts of Sophora flavescens, 30 parts of Cortex Phellodendri, 15 parts of Fructus Cnidii, 20 parts of rhubarb.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to a medicine for treating tinea pedis. The medicine is prepared from, by mass, 20-40 parts of hydnocarpus, 10-30 parts of radix sophorae flavescentis, 20-30 parts of golden cypress, 15-30 parts of fructus cnidii and 10-20 parts of rheum officinale. The medicine has the better therapeutic effect on the tinea pedis, and has no obvious toxic or side effects.
Description
technical field [0001] The invention belongs to the field of biomedicine, in particular to a medicine for treating tinea pedis. Background technique [0002] Tinea pedis is a foot skin disease caused by pathogenic fungi and is contagious. Tinea pedis is widespread throughout the world, more commonly in tropical and subtropical regions. In my country, the incidence of tinea pedis is quite high. There are no sebaceous glands on the soles of the feet and between the toes, so there is a lack of fatty acids that inhibit skin filamentous fungi, and the physiological defense function is poor. However, the skin in these parts is rich in sweat glands, and they sweat a lot. In addition, the air circulation is poor, and the local area is humid and warm. Conducive to the growth of filamentous fungi. In addition, the stratum corneum of the skin on the soles of the feet is thicker, and the keratin in the stratum corneum is a rich nutrient for fungi, which is conducive to the growth of ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K36/756A61P17/00A61P31/10
CPCA61K36/185A61K9/0014A61K36/234A61K36/489A61K36/708A61K36/756A61K2300/00
Inventor 不公告发明人
Owner 史克勇